Dr. Rosenberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4501 X St
Suite 3016
Sacramento, CA 95817- Is this information wrong?
Education & Training
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 2010
Temple University HospitalResidency, Internal Medicine, 2007 - 2009- Temple University HospitalInternship, Internal Medicine, 2006 - 2007
Icahn School of Medicine at Mount SinaiClass of 2006
Wesleyan UniversityBA, 1997 - 2001
Certifications & Licensure
CA State Medical License 2014 - 2024
MA State Medical License 2010 - 2015
PA State Medical License 2006 - 2010- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Start of enrollment: 2013 Dec 02
- Ixazomib With Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients With Multiple Myeloma Start of enrollment: 2015 Oct 01
- AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia Start of enrollment: 2016 Jun 13
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsSurvival after diffuse large B-cell lymphoma among children, adolescents, and young adults in California, 2001-2014: A population-based study.Renata Abrahão, Raul C. Ribeiro, Daphne Y. Lichtensztajn, Aaron S. Rosenberg, Theresa H.M. Keegan> ;Pediatric Blood & Cancer. 2019 Apr 1
- 11 citationsAssociation Between Autologous Stem Cell Transplant and Survival Among Californians With Multiple Myeloma.Aaron S. Rosenberg, Ann Brunson, Brian A. Jonas, Theresa H.M. Keegan, Theodore Wun> ;Journal of the National Cancer Institute. 2019 Jan 1
- 3 citationsPlatelet response to direct thrombin inhibitor or fondaparinux treatment in patients with suspected heparin-induced thrombocytopeniaTiffany K. Pon, Anjlee Mahajan, Aaron S. Rosenberg, Alpesh Amin, Digish Shah, Ian Jenkins, Vineet Gupta, Heather Hofmann, Anthony Bejjani, Richard H. White> ;Journal of Thrombosis and Thrombolysis. 2018 Mar 24
- Join now to see all
Journal Articles
- Association Between Autologous Stem Cell Transplant and Survival Among Californians with Multiple MyelomaAaron S Rosenberg, Brian A Jonas, Journal of the National Cancer Institute
Abstracts/Posters
- Blinatumomab/Lenalidomide in Relapsed/Refractory Non-HodgkinÍs Lymphoma: A Phase I California Cancer Consortium Study of Safety, Efficacy and Immune Correlative AnalysisAaron Seth Rosenberg, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Phase I Study of Escalating Doses of Carfilzomib with Hyper-CVAD in Patients with Newly Diagnosed Acute Lymphoblastic Leukemia/LymphomaAaron Seth Rosenberg, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Professional Memberships
- Member
- Member
Hospital Affiliations
University of California, Davis Medical CenterSacramento, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
